Should researchers pay for women's eggs?
By Ruha Benjamin,
San Francisco Chronicle
| 04. 04. 2013
[Op-Ed]
Many critics of the publicly funded California Institute for Regenerative Medicine have fixated on conflicts of interest that plague the state stem-cell institute's board. But a lack of constructive conflict and public deliberation over some fundamental bio-political questions poses a far greater concern.
For example: Should biotech companies who obtain CIRM grants pay sufficient royalties to the state so future therapies are affordable to low-income residents? Or will such a requirement discourage the private sector from developing treatments?
Should institutions pay women who supply their eggs for research? Or could compensation induce women of modest means to undergo the risky procedure for egg extraction?
Read more:
http://www.sfchronicle.com/opinion/openforum/article/Should-researchers-pay-for-women-s-eggs-4407876.php#ixzz2PWVMzAYr
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...